By Fred Goldstein, MS and Gregg Masters, MPH
This week join PopHealth Week hosts Gregg Masters, Doug Goldstein and Fred Goldstein for our month end review. This month’s commentary will touch upon what we learned from our first two ACO guests, Farzad Mostashari of physician led ACO management company Aledade and Gerry Meklaus of Accenture (more on tap for September as the interest level in un-bundling the model types and sharing this experience to date has been quite substantial).
We also discuss a recent interview of Ronald Bayer where he had some pretty strong thoughts on Precision Medicine versus Population Health- see: ‘Precision Medicine a Threat to Population Health‘ Is it a binary choice and might there be a need for some definitional guidance?
And as is typical Doug (@efuturist) is gallavanting around the world and we’ll get an update from him on his travels, connections and insights from ‘Digital Health España‘ aka Digitalhealth.es. Innovation is NOT limited to the domestic conversation. Doug will fill us in on his discoveries to date.
For some insights from the largest ACO in the Delaware Valley, check out Doug’s interview with Katherine Schneider, MD, President and CEO of Delaware Valley ACO.